But pharmaceutical companies are actively testing new types of weight-loss medications that may have different effects on muscle, as well as combinations of GLP-1s with other drugs meant to preserve strength
Willow , for example, ran ads encouraging patients to cancel their gym membership and promised rapid weight lossmessaging that directly contradicts clinical guidelines and feeds into unhealthy narratives (they also prescribe to patients regardless of BMI)
For pharma stakeholders, this head-to-head competition highlights opportunities in market differentiation, patient segmentation, and clinical positioning
We maintain ongoing international collaborations with institutions in Argentina, Brazil, Chile, Costa Rica, and Mexico, supporting multicenter genomic investigations of foodborne pathogens in surface waters and agricultural systems